Rationally Designed 3D Hydrogels Model Invasive Lung Diseases Enabling High-Content Drug Screening

Area of Science:

• Biomaterials Science
• Cancer Biology
• Drug Discovery

Background:

• Cell behavior and invasion are critically influenced by the microenvironment.
• Accurate drug screening for metastatic cancers requires tissue-mimetic substrates that allow cell invasion and matrix remodeling.

Purpose of the Study:

• To develop a novel biomimetic 3D hydrogel platform for quantitative analysis of cell invasion and viability.
• To utilize this platform to identify potential drug targets for invasive lung diseases, using lymphangioleiomyomatosis (LAM) as a model.

Main Methods:

• Development of a novel biomimetic 3D hydrogel platform.
• Implementation of automated data acquisition for individual cell-level analysis.
• Performance of a kinase inhibitor screen using tuberous sclerosis complex 2 (TSC2) hypomorphic cells in the hydrogel platform.

Main Results:

• The 3D hydrogel platform successfully mimics the native cellular niche and enables multiple modes of invasion.
• Phenotypic differences between healthy and diseased cells were delineated.
• The screen identified Cyclin-dependent kinase 2 (Cdk2) inhibition as a putative therapeutic strategy for LAM.

Conclusions:

• The developed 3D hydrogel platform is effective for drug screening in highly invasive diseases.
• The platform's ability to mimic native conditions and analyze individual cell behavior is critical for effective drug discovery.
• Cdk2 inhibition presents a promising therapeutic avenue for lymphangioleiomyomatosis (LAM).